当前位置： SCI文献检索 > PHARMACOECONOMICS期刊下所有文献 > Replicating Health Economic Models: Firm Foundations or a House of Cards?

Replicating Health Economic Models: Firm Foundations or a House of Cards?

Abstract：

:Health economic evaluation is a framework for the comparative analysis of the incremental health gains and costs associated with competing decision alternatives. The process of developing health economic models is usually complex, financially expensive and time-consuming. For these reasons, model development is sometimes based on previous model-based analyses; this endeavour is usually referred to as model replication. Such model replication activity may involve the comprehensive reproduction of an existing model or 'borrowing' all or part of a previously developed model structure. Generally speaking, the replication of an existing model may require substantially less effort than developing a new de novo model by bypassing, or undertaking in only a perfunctory manner, certain aspects of model development such as the development of a complete conceptual model and/or comprehensive literature searching for model parameters. A further motivation for model replication may be to draw on the credibility or prestige of previous analyses that have been published and/or used to inform decision making. The acceptability and appropriateness of replicating models depends on the decision-making context: there exists a trade-off between the 'savings' afforded by model replication and the potential 'costs' associated with reduced model credibility due to the omission of certain stages of model development. This paper provides an overview of the different levels of, and motivations for, replicating health economic models, and discusses the advantages, disadvantages and caveats associated with this type of modelling activity. Irrespective of whether replicated models should be considered appropriate or not, complete replicability is generally accepted as a desirable property of health economic models, as reflected in critical appraisal checklists and good practice guidelines. To this end, the feasibility of comprehensive model replication is explored empirically across a small number of recent case studies. Recommendations are put forward for improving reporting standards to enhance comprehensive model replicability.

journal_name

Pharmacoeconomics

journal_title

PharmacoEconomics

authors

Bermejo I,Tappenden P,Youn JH

doi

10.1007/s40273-017-0553-x

subject

Has Abstract

pub_date

2017-11-01 00:00:00

pages

1113-1121

issue

eissn

1170-7690

issn

1179-2027

pii

10.1007/s40273-017-0553-x

journal_volume

pub_type

杂志文章

在线工具

Replicating Health Economic Models: Firm Foundations or a House of Cards?